Michel O, Duchateau J, Plat G, Cantinieaux B, Hotimsky A, Gerain J, Sergysels R
Clinic of Allergology and Respiratory Diseases, Saint-Pierre University Hospital (ULB), Brussels, Belgium.
Clin Exp Allergy. 1995 Jan;25(1):73-9. doi: 10.1111/j.1365-2222.1995.tb01005.x.
Previously we have reported that in asthmatics an inhalation of 20 micrograms lipopolysaccharide (LPS) produces a bronchial obstruction associated with an inflammatory blood response. The aim of the present study was to evaluate this response in normal subjects. Eight normal non-atopic subjects were challenged by inhalation of a solution containing 20 micrograms LPS (from Escherichia coli 026:B6) a week after bronchial challenge with control solution. The lung function response was evaluated by the changes in forced expiratory volume in one second (FEV1), in specific conductance and in airway resistance while the blood inflammatory response was evaluated by serial measures of total white blood cells (WBC) and polymorphonuclear neutrophils (PMN) count, luminol enhanced-chemiluminescence (luminol-CL, as a marker of the PMN degree of activation), C-reactive protein (CRP), haptoglobin, complement fraction C3, tumour necrosis factor-alpha (TNF-alpha) and adrenocorticotropic hormone (ACTH). No response in lung function was observed for 6 h after the LPS inhalation. The count in WBC and PMN increased 300 (P < 0.01) and 360 (P < 0.01) min after the LPS challenge associated with an increase in the level of luminol-CL (P < 0.001). This rise in luminol-CL level was significant at 120 min (P < 0.05) before any change in the PMN count. After 24 and 48 h the acute-phase protein CRP raised significantly (P < 0.01), the other proteins C3 and haptoglobin being unchanged. A slight increase in ACTH was observed 240 and 360 min (P < 0.05) after the LPS challenge while the TNF alpha detectable level was not modified.(ABSTRACT TRUNCATED AT 250 WORDS)
此前我们曾报道,哮喘患者吸入20微克脂多糖(LPS)会引发支气管阻塞,并伴有炎症性血液反应。本研究的目的是评估正常受试者的这种反应。8名正常非特应性受试者在接受对照溶液支气管激发一周后,吸入含20微克LPS(来自大肠杆菌026:B6)的溶液进行激发。通过一秒用力呼气容积(FEV1)、比气道传导率和气道阻力的变化来评估肺功能反应,同时通过连续检测总白细胞(WBC)和多形核中性粒细胞(PMN)计数、鲁米诺增强化学发光(鲁米诺-CL,作为PMN活化程度的标志物)、C反应蛋白(CRP)、触珠蛋白、补体C3、肿瘤坏死因子-α(TNF-α)和促肾上腺皮质激素(ACTH)来评估血液炎症反应。吸入LPS后6小时未观察到肺功能反应。LPS激发后300分钟(P<0.01)WBC计数增加300,360分钟(P<0.01)PMN计数增加360,同时鲁米诺-CL水平升高(P<0.001)。在PMN计数未发生任何变化之前,鲁米诺-CL水平在120分钟时显著升高(P<0.05)。24小时和48小时后,急性期蛋白CRP显著升高(P<0.01),其他蛋白C3和触珠蛋白未发生变化。LPS激发后240分钟和360分钟观察到ACTH略有升高(P<0.05),而可检测到的TNF-α水平未改变。(摘要截选至250字)